Literature DB >> 20149939

Host genes associated with HIV/AIDS: advances in gene discovery.

Ping An1, Cheryl A Winkler.   

Abstract

Twenty-five years after the discovery of HIV as the cause of AIDS there is still no effective vaccine and no cure for this disease. HIV susceptibility shows a substantial degree of individual heterogeneity, much of which can be conferred by host genetic variation. In an effort to discover host factors required for HIV replication, identify crucial pathogenic pathways, and reveal the full armament of host defenses, there has been a shift from candidate-gene studies to unbiased genome-wide genetic and functional studies. However, the number of securely identified host factors involved in HIV disease remains small, explaining only approximately 15-20% of the observed heterogeneity - most of which is attributable to human lymphocyte antigen (HLA) variants. Multidisciplinary approaches integrating genetic epidemiology to systems biology will be required to fully understand virus-host interactions to effectively combat HIV/AIDS. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20149939      PMCID: PMC3792714          DOI: 10.1016/j.tig.2010.01.002

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  106 in total

1.  Distinct transcriptional profiles in ex vivo CD4+ and CD8+ T cells are established early in human immunodeficiency virus type 1 infection and are characterized by a chronic interferon response as well as extensive transcriptional changes in CD8+ T cells.

Authors:  Martin D Hyrcza; Colin Kovacs; Mona Loutfy; Roberta Halpenny; Lawrence Heisler; Stuart Yang; Olivia Wilkins; Mario Ostrowski; Sandy D Der
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

2.  Identification of novel therapeutic targets for HIV infection through functional genomic cDNA screening.

Authors:  Deborah G Nguyen; Hong Yin; Yingyao Zhou; Karen C Wolff; Kelli L Kuhen; Jeremy S Caldwell
Journal:  Virology       Date:  2007-01-25       Impact factor: 3.616

3.  Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G: a possible role in the resistance to HIV of HIV-exposed seronegative individuals.

Authors:  Mara Biasin; Luca Piacentini; Sergio Lo Caputo; Yasuyoshi Kanari; Giuliana Magri; Daria Trabattoni; Valentina Naddeo; Lucia Lopalco; Alberto Clivio; Eugenio Cesana; Francesca Fasano; Cristina Bergamaschi; Francesco Mazzotta; Masaaki Miyazawa; Mario Clerici
Journal:  J Infect Dis       Date:  2007-02-16       Impact factor: 5.226

4.  A haplotype of the human CXCR1 gene protective against rapid disease progression in HIV-1+ patients.

Authors:  A Vasilescu; Y Terashima; M Enomoto; S Heath; V Poonpiriya; H Gatanaga; H Do; G Diop; T Hirtzig; P Auewarakul; D Lauhakirti; T Sura; P Charneau; S Marullo; A Therwath; S Oka; S Kanegasaki; M Lathrop; K Matsushima; J-F Zagury; F Matsuda
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-21       Impact factor: 11.205

5.  RANTES -28G delays and DC-SIGN - 139C enhances AIDS progression in HIV type 1-infected Japanese hemophiliacs.

Authors:  Yusuke Koizumi; Seiji Kageyama; Yoshihide Fujiyama; Michiko Miyashita; Raphael Lwembe; Keiki Ogino; Tatsuo Shioda; Hiroshi Ichimura
Journal:  AIDS Res Hum Retroviruses       Date:  2007-05       Impact factor: 2.205

6.  Polymorphisms in IRF-1 associated with resistance to HIV-1 infection in highly exposed uninfected Kenyan sex workers.

Authors:  Terry Blake Ball; Hezhao Ji; Joshua Kimani; Paul McLaren; Crystal Marlin; Adrian V S Hill; Francis Allan Plummer
Journal:  AIDS       Date:  2007-05-31       Impact factor: 4.177

7.  APOBEC3G levels predict rates of progression to AIDS.

Authors:  Xia Jin; Hulin Wu; Harold Smith
Journal:  Retrovirology       Date:  2007-03-20       Impact factor: 4.602

8.  A whole-genome association study of major determinants for host control of HIV-1.

Authors:  Jacques Fellay; Kevin V Shianna; Dongliang Ge; Sara Colombo; Bruno Ledergerber; Mike Weale; Kunlin Zhang; Curtis Gumbs; Antonella Castagna; Andrea Cossarizza; Alessandro Cozzi-Lepri; Andrea De Luca; Philippa Easterbrook; Patrick Francioli; Simon Mallal; Javier Martinez-Picado; José M Miro; Niels Obel; Jason P Smith; Josiane Wyniger; Patrick Descombes; Stylianos E Antonarakis; Norman L Letvin; Andrew J McMichael; Barton F Haynes; Amalio Telenti; David B Goldstein
Journal:  Science       Date:  2007-07-19       Impact factor: 47.728

9.  Population stratification of a common APOBEC gene deletion polymorphism.

Authors:  Jeffrey M Kidd; Tera L Newman; Eray Tuzun; Rajinder Kaul; Evan E Eichler
Journal:  PLoS Genet       Date:  2007-04-20       Impact factor: 5.917

10.  Regulatory polymorphisms in the cyclophilin A gene, PPIA, accelerate progression to AIDS.

Authors:  Ping An; Li Hua Wang; Holli Hutcheson-Dilks; George Nelson; Sharyne Donfield; James J Goedert; Charles R Rinaldo; Susan Buchbinder; Gregory D Kirk; Stephen J O'Brien; Cheryl A Winkler
Journal:  PLoS Pathog       Date:  2007-06       Impact factor: 6.823

View more
  47 in total

1.  Genome-wide association study of neurocognitive impairment and dementia in HIV-infected adults.

Authors:  Andrew J Levine; Susan Service; Eric N Miller; Sandra M Reynolds; Elyse J Singer; Paul Shapshak; Eileen M Martin; Ned Sacktor; James T Becker; Lisa P Jacobson; Paul Thompson; Nelson Freimer
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-05-24       Impact factor: 3.568

Review 2.  Mendelian randomization: potential use of genetics to enable causal inferences regarding HIV-associated biomarkers and outcomes.

Authors:  Weijing He; John Castiblanco; Elizabeth A Walter; Jason F Okulicz; Sunil K Ahuja
Journal:  Curr Opin HIV AIDS       Date:  2010-11       Impact factor: 4.283

3.  Host genomic HIV restriction factors modulate the response to dendritic cell-based treatment against HIV-1.

Authors:  Alessandra Pontillo; Ronaldo C Da Silva; Ronald Moura; Sergio Crovella
Journal:  Hum Vaccin Immunother       Date:  2013-11-15       Impact factor: 3.452

4.  Control of M184V HIV-1 mutants by CD8 T-cell responses.

Authors:  Thomas Vollbrecht; Josef Eberle; Julia Roider; Silja Bühler; Renate Stirner; Nadja Henrich; Ulrich Seybold; Johannes R Bogner; Rika Draenert
Journal:  Med Microbiol Immunol       Date:  2011-12-27       Impact factor: 3.402

5.  Genome-wide association study implicates PARD3B-based AIDS restriction.

Authors:  Jennifer L Troyer; George W Nelson; James A Lautenberger; Leslie Chinn; Carl McIntosh; Randall C Johnson; Efe Sezgin; Bailey Kessing; Michael Malasky; Sher L Hendrickson; Guan Li; Joan Pontius; Minzhong Tang; Ping An; Cheryl A Winkler; Sophie Limou; Sigrid Le Clerc; Olivier Delaneau; Jean-François Zagury; Hanneke Schuitemaker; Daniëlle van Manen; Jay H Bream; Edward D Gomperts; Susan Buchbinder; James J Goedert; Gregory D Kirk; Stephen J O'Brien
Journal:  J Infect Dis       Date:  2011-05-15       Impact factor: 5.226

6.  Regulatory variation in HIV-1 dependency factor ZNRD1 associates with host resistance to HIV-1 acquisition.

Authors:  Ping An; James J Goedert; Sharyne Donfield; Susan Buchbinder; Gregory D Kirk; Roger Detels; Cheryl A Winkler
Journal:  J Infect Dis       Date:  2014-05-19       Impact factor: 5.226

7.  Host genetics contributes to the effectiveness of dendritic cell-based HIV immunotherapy.

Authors:  Edione C Reis; Lais T da Silva; Wanessa C da Silva; Alexandre Rios; Alberto J Duarte; Telma M Oshiro; Sergio Crovella; Alessandra Pontillo
Journal:  Hum Vaccin Immunother       Date:  2018-05-17       Impact factor: 3.452

8.  Novel biopanning strategy to identify epitopes associated with vaccine protection.

Authors:  Barbara C Bachler; Michael Humbert; Brisa Palikuqi; Nagadenahalli B Siddappa; Samir K Lakhashe; Robert A Rasmussen; Ruth M Ruprecht
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

Review 9.  Genetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorder.

Authors:  Andrew J Levine; Stella E Panos; Steve Horvath
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

10.  The Loss-of-Function S267F Variant in HBV Receptor NTCP Reduces Human Risk for HBV Infection and Disease Progression.

Authors:  Ping An; Zheng Zeng; Cheryl A Winkler
Journal:  J Infect Dis       Date:  2018-09-22       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.